Cite
Scaricamazza S, Salvatori I, Amadio S, et al. Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1. Br J Pharmacol. 2021;doi: 10.1111/bph.15738.
Scaricamazza, S., Salvatori, I., Amadio, S., Nesci, V., Torcinaro, A., Giacovazzo, G., Primiano, A., Gloriani, M., Candelise, N., Pieroni, L., Loeffler, J. P., Renè, F., Quessada, C., Tefera, T. W., Wang, H., Steyn, F. J., Ngo, S. T., Dobrowolny, G., Lepore, E., Urbani, A., Musarò, A., Volonté, C., Ferraro, E., Coccurello, R., Valle, C., & Ferri, A. (2021). Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1. British journal of pharmacology, . https://doi.org/10.1111/bph.15738
Scaricamazza, Silvia, et al. "Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1." British journal of pharmacology vol. (2021). doi: https://doi.org/10.1111/bph.15738
Scaricamazza S, Salvatori I, Amadio S, Nesci V, Torcinaro A, Giacovazzo G, Primiano A, Gloriani M, Candelise N, Pieroni L, Loeffler JP, Renè F, Quessada C, Tefera TW, Wang H, Steyn FJ, Ngo ST, Dobrowolny G, Lepore E, Urbani A, Musarò A, Volonté C, Ferraro E, Coccurello R, Valle C, Ferri A. Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1. Br J Pharmacol. 2021 Nov 16; doi: 10.1111/bph.15738. Epub 2021 Nov 16. PMID: 34783031.
Copy
Download .nbib